SHIFT AI Newsroom · GLOBAL
Platform Trial for Pediatric Obesity or Overweight (LY900040) Registered
A platform trial, LY900040, has been registered to investigate treatments for pediatric participants with obesity or overweight.
A platform trial, LY900040, has been registered to investigate treatments for pediatric participants with obesity or overweight. The trial is currently in the recruitment phase, but details about the specific treatments being investigated are not yet available. The outcomes of the trial are also unknown at this time.
What this means in the UK
This trial may potentially lead to new treatments for pediatric obesity or overweight, which could have implications for UK healthcare if the treatments are proven safe and effective and subsequently approved for use in the UK.
Known facts
- A platform trial, LY900040, has been registered for pediatric participants with obesity or overweight.